Doppler ultrasonography of the vertebrobasilar... (2005 study) Skip to main content
Clinical Study The Journal of otolaryngology 2005

Doppler ultrasonography of the vertebrobasilar circulation in patients with sudden sensorineural hearing loss.

Grgić M, Petric V, Grgić MP, Demarin V, Pegan B, The Journal of otolaryngology, 2005

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers used ultrasound to look at blood flow at the back of the brain in 32 people with sudden hearing loss, and compared hearing levels with those findings before treatment, after 10 days, and after 3 months.

What They Found

In a case-control study of 32 patients with sudden sensorineural hearing loss treated with pentoxifylline infusions, patients with normal transcranial Doppler findings improved by an average of 17 dB, while those with abnormal findings improved less. Thirteen patients had normal findings, eight had borderline findings, and six had pathologic findings. Average hearing improvement was 3 dB in the borderline group and 0 dB in the pathologic group. In five patients, the initially pathologic findings improved during therapy, and these patients had the greatest average hearing improvement, 28 dB. The abstract reports that patients with hearing loss had more frequent pathologic findings than a normal population.

What This Means for Canadian Patients

The abstract does not address hyperbaric oxygen therapy. It covers only pentoxifylline treatment and ultrasound of blood flow in sudden hearing loss. The authors suggest that blood-vessel problems may play a role in some patients and that ultrasound might help guide treatment choice, but they note the number of patients is small.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was small, with only 32 patients and no randomised comparison of treatments, so the authors describe their conclusions as applying to at least some patients.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 15966478
Year Published 2005
Journal The Journal of otolaryngology
MeSH Terms Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Basilar Artery; Carbon Dioxide; Case-Control Studies; Cochlea; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Immunosuppressive Agents; Interferon-alpha

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology